Results 61 to 70 of about 578 (168)

Effect on Cell Surface Markers following Allergen-Induced Desensitization of Human Whole-Blood Basophils

open access: yes, 2010
<i>Background:</i> Allergen-specific immunotherapy (SIT) leads to reduced symptoms upon allergen exposure through as yet unresolved mechanisms.
Jens Holm   +4 more
core   +1 more source

Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case Report

open access: yesHLA, Volume 107, Issue 5, May 2026.
ABSTRACT Tebentafusp, a T‐cell receptor‐bispecific molecule targeting glycoprotein 100‐derived peptide presented by HLA class I molecule and CD3, is standard of care for patients with unresectable or metastatic uveal melanoma who are positive for HLA‐A*02:01. Mechanisms of resistance to tebentafusp are unknown. We report a patient with metastatic uveal
Halime Kalkavan   +13 more
wiley   +1 more source

A Pilot Randomised Controlled Dose‐Ranging Trial of Ant Venom Immunotherapy With and Without Delta‐Inulin Adjuvant

open access: yesClinical &Experimental Allergy, Volume 56, Issue 4, Page 378-390, April 2026.
Low dose (25mcg) jack jumper ant venom immunotherapy with or without Advax adjuvant, had similar efficacy to the current standard of care. Reduction in basophil activation test reactivity in response to treatment correlated with sting challenge outcome.
Thanh‐Thao Adriana Le   +14 more
wiley   +1 more source

Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy

open access: yes, 2018
Allergen-specific immunotherapy for house dust mite allergy is effective, but there are no validated biomarkers reflecting or predicting the clinical efficacy. We aimed to investigate the relationship between clinical outcomes and functional responses of
Qiujuan Su   +8 more
core   +1 more source

Prolonged IL‐33 Exposure Switches the Secreted Mast Cell Cytokine Profile From Pro‐Inflammatory to Pro‐Tolerant

open access: yesAllergy, Volume 81, Issue 3, Page 720-733, March 2026.
This study investigates the effect of IL‐33 and Hymenoptera venom on mast cell cytokine profiles under venom immunotherapy (VIT)‐like conditions. Our in vitro model of VIT‐like mast cell stimulation demonstrates a modulatory effect of IL‐33 on the secreted mast cell cytokine profile.
Andrea R. Teufelberger   +3 more
wiley   +1 more source

Rate Of Anaphylaxis Caused By Oral Immunotherapy In Children With Cow's Milk Allergy

open access: yes, 2014
Rationale The safety represents the major concern for the treatment of IgE mediated food allergy with oral immunotherapy (OIT). The aim of the survey was the detection of the rate of Anaphylaxis during immunotherapy with cow’s milk (CM – OIT).Methods
SALZANO, Giuseppina   +6 more
core   +1 more source

How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers

open access: yes, 2020
Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU). In routine clinical practice, physicians often face complex cases of CSU and need to decide whether patients are suitable for omalizumab treatment and how to ...
TÜRK, MURAT   +5 more
core   +1 more source

Simulating the impact of an educational and digital approach using patient journey modelling to overcome practical challenges in the management of chronic spontaneous urticaria in Germany

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-346, March 2026.
Summary Background and Objective Despite the availability of guidelines and effective escalation therapies, chronic spontaneous urticaria (CSU) is often inadequately treated in Germany. Implementation science can help to transfer evidence‐based care into practice.
Ralph von Kiedrowski   +10 more
wiley   +1 more source

Safety and efficiency of peanut oral immunotherapy in preschool children with slow up-dosing and low maintenance dosing: a randomised controlled trialResearch in context

open access: yesThe Lancet Regional Health. Europe
Summary: Background: Oral immunotherapy (OIT) is an emerging treatment for peanut allergy. A variety of protocols have been investigated, and accumulating evidence suggests that younger children may benefit from greater immune plasticity. The aim of the
Susanna Klevebro   +10 more
doaj   +1 more source

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

open access: yesAllergy, Volume 81, Issue 2, Page 427-453, February 2026.
The Allergic Rhinitis and its Impact on Asthma (ARIA) group is working on the 2024–2025 update of its guidelines for the management of allergic rhinitis (ARIA 2024–2025). The ARIA 2024–2025‐EAACI guidelines will follow GRADE methodology and will incorporate evidence from different sources, including systematic reviews and meta‐analyses, mHealth data ...
Jean Bousquet   +230 more
wiley   +1 more source

Home - About - Disclaimer - Privacy